Annual Report 2003 - Nobel Biocare Corporate

NOBEL BIOCARE ANNUAL REPORT 200337Consolidated balance sheetIN EUR'00031 DECEMBER NOTE 2003 2002SHAREHOLDERS’ EQUITY AND LIABILITIESShare capital 32 687 34 551Share premium 79 611 58 690Treasury shares -359 -Retained earnings 171 517 119 494Shareholders’ equity 16 283 456 212 735Minority interest 16 2 507 2 202Interest-bearing loans 18 748 29 884Deferred tax liabilities 21 7 396 2 648Provisions 20 22 354 22 932Total non-current liabilities 30 498 55 464Interest-bearing loans 18 73 1 196Trade payables 22 9 057 13 761Income tax payables 15 481 9 330Other liabilities 14 599 7 212Accrued expenses and deferred income 23 22 849 22 353Total current liabilities 62 059 53 852Total liabilities 92 557 109 316TOTAL SHAREHOLDERS’ EQUITY AND LIABILITIES 378 520 324 253